The Western Neuropathy Association provides grants to research focused on treating and managing peripheral neuropathy.
Learn more about our past funding below.
Check our Neuropathy Hope Newsletter for the latest publications in research and clinical trials for peripheral neuropathy!
EC5026 (Dr. Bruce Hammock)
Dr. Bruce Hammock, Distinguished Professor at University of California at Davis (UC Davis), and CEO and founder of EicOsis - a California-based startup company, has been working on a non-narcotic oral pain relief medication known as EC5026. EC5026 addresses inflammatory and neuropathic pain in humans and companion animals, working in both the central and peripheral nerve systems.
The Western Neuropathy Association (WNA) has provided Dr. Hammock and his team with $15,000 in funding, allowing his team to purchase equipment other grants would not cover, and more.
See past media releases from WNA's Neuropathy Hope Newsletter regarding EC5026 below.
- January / February 2024: https://pnhelp.org/application/files/3417/0915/7275/WNA-ENews-01-02-24.pdf
- January / February 2023: https://pnhelp.org/application/files/7316/7934/1677/WNA-ENews-0123-0223.pdf
- January 2020: https://pnhelp.org/application/files/5215/7720/5010/WNAENews-0120L.pdf
To learn more and see updates about clinical trials for EC5026, you can also visit EicOsis's website at https://www.eicosis.com/ .
Future Funding
Are you part of a research team working on medications, treatments, and other clinical trials?
We continue to look for webinar presenters, articles pertaining to people with peripheral neuropathy, and research and clinical trials that can improve quality of life.
Should your research hold the potential to enhance the quality of life for individuals affected by peripheral neuropathy, we encourage you to contact us to explore whether our grant program aligns with your objectives.
The Western Neuropathy Association prides itself on keeping up to date on the latest research pertaining to peripheral neuropathy.
Attend a support group meeting to hear timely reports of what we've read and learned, and consider becoming a member to receive the newest editions of the Neuropathy Hope Newsletter.